Propylthiouracil is a prescription drug used to treat hyperthyroidism (overactive thyroid) due to Graves’ diseases. In April 2010, the Food and Drug Administration (FDA) added a Boxed Warning to the label for propylthiouracil to include information about reports of severe liver injury and acute liver failure, some of which have been fatal, in adult and pediatric patients using this medication.
The new warning also states that for patients just beginning treatment for hyperthyroidism, it may be appropriate to reserve the use of propylthiouracil for those unable to tolerate other therapies, including methimazole, radioactive iodine, or surgery. In pregnant patients, propylthiouracil may be the treatment of choice during and just before the first trimester of pregnancy because of the observed occurrence of birth defects with methimazole use.
If you or your loved one has suffered a Propylthiouracil-PTU injury, contact us today. Submit the form to the right and we’ll let you know if you have a case and if we can represent you.